RSS   Newsletter   Contact   Advertise with us
Post Online Media

Momenta Pharmaceuticals adds Corey N. Fishman to board

MomentaMomenta Pharmaceuticals, a biotechnology company, announced the appointment of Corey N. Fishman to its board of directors.

Mr. Fishman currently serves as Chief Executive Officer of Iterum Therapeutics Limited, a clinical-stage pharmaceutical company developing differentiated anti-infectives for combatting multi-drug resistant pathogens.

Article continues below

READ MORE Momenta Pharmaceuticals names Matthew P. Ottmer as COO

Mr. Fishman has served as Chief Executive Officer of Iterum Therapeutics Limited since its founding in late 2015.

He served as Chief Financial and Chief Operating Officer of Durata Therapeutics where he managed a successful IPO and secondary offering, and led the negotiation and sale of the company to Actavis.

Prior to Durata, Mr. Fishman served as Chief Financial Officer of Ganic Pharmaceuticals, a Warburg Pincus Company, and served in several leadership roles, including Chief Financial Officer, at MedPointe Healthcare.

Mr. Fishman holds a BA in Economics from the University of Illinois at Urbana-Champaign and an MSM in Finance from the Krannert School of Management at Purdue University.


 LATEST MOVES FROM Massachusetts 





More inside POST
 
 

We use cookies to ensure that we give you the best experience on our website. Please allow cookies for fully-functioning website.

Allow Cookies Privacy Policy